Research Group
              Cancer Biomarkers
                    Sponsor
                    M.D. Anderson Cancer Center
                Status
                    Recruiting
                NCT ID
                    NCT00539162
                The goal of this clinical research study is to evaluate a method involving 4 blood tests called CA-125, HE4, HE4 antigen autoantibody complexes, and osteopontin that may be helpful in the early detection of ovarian cancer in women who are at low risk.
            
  
  
      Intervention
                    Questionnaire
                Condition
                    Ovarian Cancer
                Investigators
                    Denise Nebgen, MD, PHD, Brian Slomovitz, MD, Georgia McCann, MD, Richard Moore, MD, Laura Holman, MD, Marian Williams-Brown, MD, Karen H. Lu, MD
                